You are here

  1. Home
  2. California Transparency in Supply Chains Act (CATSCA)

California Transparency in Supply Chains Act (CATSCA)

CATSCA legislation becomes effective on January 1, 2012.  This legislation requires that manufacturers doing business in California ($100M+) disclose the efforts they take to ensure product supply chains are free of slave labor and human trafficking.  The intent of this legislation is to help consumers make informed choices and to encourage businesses to ensure humane practices throughout the supply chain.
 

Specifically, the California entities of Saint-Gobain must disclose the extent that we:

  • Verify product supply chains to evaluate and address risks of human trafficking and slavery.
  • Audit suppliers to evaluate compliance with our company standards for trafficking and slavery in supply chains.
  • Require direct suppliers to certify compliance with the laws regarding slavery and human trafficking of the country or countries in which the suppliers are doing business.
  • Maintain internal accountability standards and procedures for employees and/or contractors failing to meet company standards regarding slavery and trafficking.
  • Provide company employees, who have direct responsibility for supply chain management, training on human trafficking and slavery, particularly with respect to mitigating risks within the supply chains of product.

 Saint-Gobain requests that all products supplied to our manufacturing facilities in the state of California comply with the company's policy of compliance with the California Transparency of Supply Chains Act of 2010. 

CATSCA Supplier Notification Form

Suppliers are required to provide required certification.  Select for more details and compliance information.

About Saint-Gobain

Saint-Gobain designs, manufactures and distributes materials and solutions which are key ingredients in the wellbeing of each of us and the future of all. They can be found everywhere in our living places and our daily life: in buildings, transportation, infrastructure and in so many industrial applications.

 

Saint-Gobain Performance Plastics' group of businesses gather solutions to save energy, provide protection, improve comfort and sustain the environment for a variety of markets.

MENU

Capabilities
Materials
Markets
Resources
FAQs
About Us
Contact Us
Schedule a Lunch and Learn
Legal
CATSCA

 

 

 

FOLLOW US

 

 CONTACT US

Saint-Gobain’s medical products are distributed exclusively to medical device manufacturers for use in the manufacture, assembly or distribution of their medical devices. Saint-Gobain cannot authorize the sale of its medical products directly to device user facilities (e.g. hospitals, surgery centers, nursing home, clinics, etc.), nor directly to end users (e.g. patients, patients’ caregiver, prescribing physician, nurse, pharmacist, etc.), including distributors serving device user facilities and end users directly. In accordance with every jurisdiction globally, Saint-Gobain’s customers are responsible for determining that any medical device they manufacture and market that incorporates a Saint-Gobain’s medical product, is compliant with each country-specific medical device regulations and has received proper country-specific clearance, certification or registration authorizing the sale of this medical device.


Saint-Gobain’s medical products offer covers:
- Medical Components [21 CFR 820.3(c)], intended for processing or use in the manufacture or assembly of medical devices before the finished medical device is packaged/labeled; Medical Components are intended to be included as part of the finished, packaged, and labeled device [21CFR820.3(c)].
- Finished Devices [21CFR820.3(l)] made on behalf of medical device manufacturers [21 CFR 807.20(a)(2)] under contract-manufacturing agreement. In accordance with the United States’ jurisdiction, Saint-Gobain complies with the FDA’s requirements for contract manufacturers of finished devices.

© Copyright Saint-Gobain 2019. All rights reserved.